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ABSTRACT
Objective Delayed prescribing is a promising strategy 
to manage patient requests for unnecessary tests and 
treatments. The purpose of this study was to explore 
general practitioner (GP) and patient views of three 
communication tools (Overdiagnosis Leaflet, Dialogue 
Sheet and ‘Wait- and- see’ Note) to support delayed 
prescribing of diagnostic imaging.
Design Qualitative study.
Setting Primary and emergency care in Sydney, Australia.
Participants 16 GPs and 14 patients with recent episode 
of low back pain.
Outcome Views on the tools to delay diagnostic imaging 
for low back pain. Data were collected using a combination 
of focus groups and individual interviews.
Analysis Two researchers independently performed a 
thematic analysis, and the author team reviewed and 
refined the analysis.
Results GP participants responded positively to the 
Overdiagnosis Leaflet. The Dialogue Sheet and ‘Wait- and- 
see’ Note raised several concerns about patient pushback, 
adding to time pressure and being overwhelmed 
with hard- to- find paper resources. GPs preferred to 
communicate verbally the reasons to delay an imaging 
test. For patients, the reactions to the tools were more 
positive. Patients valued written information and a signed 
agreement to delay the test. However, patients expressed 
that a strong desire for diagnostic imaging would likely 
over- ride any effect of written advice to delay the test. The 
term ‘false alarm’ to describe overdiagnosis was poorly 
understood by patients.
Conclusions GPs and patients agreed that a leaflet about 
overdiagnosis could support a delayed prescribing approach 
to imaging for low back pain. The Dialogue Sheet and ‘Wait- 
and- see’ Note were acceptable to patients but not to GPs.
INTRODUCTION
Guidelines for low back pain recommend that 
clinicians reserve diagnostic imaging tests for 
patients who have clinical features of serious 
pathology.1 Yet on average general practi-
tioners (GP) refer around a quarter of their 
patients with low back pain for imaging.2 In 
most cases these tests will not bring patients 
any benefit.3 Instead, overuse of imaging has 
negative consequences for the patient, the 
clinician and for health systems.4
A number of factors related to the patient–
clinician interaction could drive overuse of 
imaging for low back pain. A review of 17 
qualitative studies identified ‘perceived pres-
sure from patients’ as a key driver of guideline- 
discordant imaging reported by doctors.5 
Indeed, around 50% of patients with low back 
pain believe imaging is necessary.6 Also, many 
clinicians worry about medicolegal liability if 
they do not provide the test, and feel they lack 
tools to discuss the need for imaging with their 
patients.7
Tools that promote watchful waiting as an 
evidence- based alternative to imaging could be 
effective at reducing overuse. For example, infor-
mation leaflets to support delayed prescribing, 
that is, where a GP provides a script but instructs 
the patient to wait and see if symptoms resolve, 
can reduce use of antibiotics.8 One trial in the 
1980s found this approach reduced imaging for 
low back pain.9 There is evidence that written 
delayed prescribing tools are acceptable to 
patients who are considering antibiotics and 
some screening tests.10 11 However, it is unclear 
how GPs and patients might react to tools for 
symptomatic conditions where imaging overuse 
is problematic.
Strengths and limitations of this study
 ► Understanding how both general practitioners (GPs) 
and patients might use communication tools will 
help inform strategies to reduce overuse of diagnos-
tic imaging.
 ► Our data collection methods allowed us to capture 
natural conversations in the focus groups and ex-
plore emergent themes in depth in the interviews.
 ► GPs included in this study were attending a profes-
sional education event and may have had more pos-
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In 2019 the Australian Government Department of 
Health developed a resource pack to support GPs as part 
of a broader programme of work to reduce unnecessary 
diagnostic imaging for musculoskeletal pain. The pack 
included three newly developed communication tools. 
One was developed by the lead author in collaboration 
with an advertising agency (Overdiagnosis Leaflet). The 
remaining two tools (Dialogue Sheet and ‘Wait- and- see’ 
Note) were developed by the Department of Health and 
with input from researchers and clinicians within the 
Wiser Healthcare Research Collaboration. The goal of 
the tools was to encourage discussions between patients 
and clinicians about the need for imaging and support 
a delayed prescribing approach to reduce unnecessary 
requests. Before deciding whether they would distribute 
the tools to GPs, the Department of Health commissioned 
a qualitative evaluation, which we describe here.
The aim of this study was to gather GP and patient views 
on the three newly developed communication tools to 
support delayed prescribing of imaging for low back pain.
METHODS
Study design and participants
We conducted a qualitative study with four focus groups 
and eight individual interviews to explore how GPs and 
patients understood and responded to the communica-
tion tools. We have prepared this report to adhere to the 
Consolidated criteria for Reporting Qualitative research 
checklist (see online supplemental appendix 1).12
We used convenience sampling to select participants. 
We aimed to conduct a minimum of two focus groups 
of at least five participants for each participant type. We 
planned additional ‘mop- up’ individual interviews which 
took place until saturation was reached. GPs who were 
practising in Australia were eligible to participate. For GP 
participants we recruited a sample of GPs who attended 
a continuing professional development event on 30 July 
2019. Of the 23 GPs attending the event who were invited 
and eligible, 12 agreed to participate in a focus group. 
We recruited an additional four GP participants to partic-
ipate in individual interviews, from a separate study. That 
study’s aim was to explore GP perceptions of audit and 
feedback letters focused on diagnostic imaging for muscu-
loskeletal conditions. After the interview about the audit 
and feedback letter intervention, GPs were invited to take 
the three tools away with them to use in their practice, 
for a period of 3 weeks (GPs in the focus groups were not 
given this opportunity). Because they were participating 
in a separate study, the four GPs who participated in indi-
vidual interviews were aware of a broader programme of 
work to reduce unnecessary care by the Department of 
Health.
For the patient participants we recruited men and 
women who had sought care for low back pain between 
March and June 2019. We identified a consecutive list 
of adult patients who presented with ‘non- serious’ low 
back pain to the Emergency Department of Liverpool 
Hospital, Sydney. Patient participants were approached 
using text messages from the hospital clinician and 
research team. Of the 40 patients who were invited and 
eligible, 10 agreed to participate in a focus group and 4 
in an individual phone interview.
Data collection
The research team comprised a physiotherapist and 
research fellow (ACT); a PhD student with back-
ground in sociology (SS); two staff from the Depart-
ment of Health (JC, PV); a senior physiotherapist 
(ET); a qualitative research assistant (CK); a GP and 
research fellow (LA); a senior research fellow (DAO); 
and an expert in qualitative research and professor of 
public health (KM). The focus groups were facilitated 
by ACT, SS, JC, PV and CK. The interviews were facili-
tated by CK, JC and DAO. The focus groups consisted 
of one male and three female facilitators. The inter-
viewers (CK, JC, DAO) were female. ACT, JC and CK 
had experience with qualitative methods, including 
facilitating focus groups and interviews.
Researchers had no professional or ongoing rela-
tionship with the participants. Participants were 
informed that the researchers were interested in 
exploring the use of diagnostic imaging for muscu-
loskeletal pain. The study was introduced to partic-
ipants as an initiative to better understand the use 
of, and communication about, imaging for low back 
pain. Prior to beginning the sessions participants 
completed a written demographic questionnaire so 
that we could describe the sample. We asked all partic-
ipants whether they agreed with the following state-
ment: ‘Everyone who gets low back pain should have 
an imaging test (x- Ray, CT, MRI)’. Patients were asked 
an additional question about their history of imaging 
for low back pain. GPs were asked questions regarding 
years of practice, their self- reported imaging rate and 
their interest in musculoskeletal conditions.
We audio- recorded all focus group discussions and inter-
views. The recordings were transcribed verbatim. Tran-
scripts were not returned to participants for comment or 
correction. Facilitators made field notes throughout the 
interviews and identified salient themes. After the focus 
groups, the facilitators involved in the sessions (ACT, CK, 
PV, JC, SS, ET) independently documented their obser-
vations and emerging key themes. They then discussed 
these initial themes as a team.
Focus groups
Each group comprised five to seven people. The 
sessions had the following format: demographic 
questionnaire, introduction of study and facilitators, 
warm- up discussion, presentation of the tools (Power-
Point slides plus paper versions), and guided discus-
sion of each tool (box 1). We held the sessions with 
GPs at the Institute for Musculoskeletal Health, a clin-
ical research institute at the University of Sydney, on 
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conference facility attached to Liverpool Hospital in 
Sydney on 23 August 2019. ET attended one of the 
patient focus groups as an observer. The focus group 
sessions lasted 60–90 min and had at least two facilita-
tors from the author team.
Interviews
After the focus groups DAO and JC conducted additional 
individual interviews with four GPs, and CK conducted 
additional interviews with four patients. Interviews were 
conducted over the phone. We used these additional 
‘mop- up’ interviews to further explore salient themes 
that emerged in the focus groups. We stopped recruiting 
patients for interviews when no new themes emerged 
(data saturation).13 Recruitment of GP participants for 
interviews was limited by resources and not necessarily by 
data saturation. The interview sessions lasted 20–40 min. 
No repeat interviews were carried out.
Communication tools and discussion content
Table 1 describes the rationale and content of the three 
communication tools. We selected these three tools 
because they were being used in a broader programme 
of work to reduce unnecessary diagnostic imaging by the 
Department of Health. Complete versions of the tools 
are included in online supplemental appendix 2. The 
focus groups and interviews followed a similar discussion 
format (box 1). The interview guide was not pilot- tested. 
Box 1 Focus group and interview topic guide
All participants.
 ► Participants take turns to read the tools and ‘think aloud’ as they 
read the content.
 ► Which elements of the tools did you like? Why?
 ► Which elements of the tools did you not like? Why?
 ► Do you have any suggestions for improvement?
For general practitioner participants.
 ► Are any of these tools something that you would use? What would 
improve usability?
For patient participants.
 ► Did you gain any new information about imaging from these tools? If 
your doctor went through these tools with you, how would you feel? 
What would improve usability?
Table 1 Description and intended use of tools to support delayed prescribing of musculoskeletal imaging
Overdiagnosis Leaflet Dialogue Sheet Wait- and- see Note
Why: rationale Goal Goal Goal
Promote watchful waiting for 
people with low back pain.
Promote watchful waiting for people 
with musculoskeletal pain (including low 
back pain).
Promote watchful waiting for people 
with musculoskeletal pain (including 
low back pain).
Raise awareness of non- essential 
or ‘low- value’ lumbar imaging 
tests.
Support doctor–patient communication 
and joint decision- making.
Support doctor–patient communication 
and joint decision- making.
  Provide actions for patients to take to 





6- panel A4 folded leaflet 1- page A5 sheet 2- sided A6 note
Designed by advertising company 
and researchers.
Designed by the Department of Health 
and researchers.
Designed by the Department of Health 
and researchers.
Key messages Key messages Key message
Unnecessary lumbar scans can 
cause harm.
In your case I think imaging is 
unnecessary.
The referral is a backup; only to be 
used under specific circumstances 
(tailored to the patient).
There are alternatives to imaging. I recommend we delay decision to have 
a scan.
  
Speak to your doctor. There are other actions you can take to 
address your pain.
  
Behavioural prompts Behavioural prompts Behavioural prompts
Framing of harms from 
overdiagnosis.
Present no imaging as the default. Present no imaging as the default.
Appeal to authority (quote from 
orthopaedic surgeon)
Co- signature (patient and doctor) 
commitment to delay.
Co- signature (patient and doctor) 
commitment to delay.
Tailoring: to the 
individual
None. Space to describe symptoms, things 
to look out for, name and date, 
customisable reasons to delay, and 
recommended actions to manage pain 
and assist recovery.
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Each started with a short warm- up discussion of the role 
of diagnostic imaging in low back pain. Participants were 
then presented with the three tools, in turn, for discussion.
Data analysis
Because this project worked to a strict timeline to meet 
Department of Health operational requirements, we 
chose to conduct focus groups primarily to capture the 
views of several participants in a short time frame.
We performed a thematic analysis to identify the 
main themes as well as divergent views.14 Our thematic 
approach focused on individual experiences and reac-
tions arising from the data and across case compari-
sons. We started by analysing the focus groups first. Two 
authors coded the data from the focus groups (ACT, 
CK) using Microsoft Word and a third (SS) reviewed the 
transcripts and coding. The research team met to discuss 
the themes emerging from the focus groups and inter-
pretation of the data. Key themes that the team agreed 
on were used to develop an initial coding framework for 
the data. These discussions of findings from the focus 
groups also led to refinement of the discussion guide 
for the individual interviews. We developed a library of 
codes in an iterative process, decided on a coding frame-
work and applied this framework to the entire data set. A 
refined version of the coding tree is provided in box 2. We 
used a ‘constant comparison’ approach, which involves 
continually looking for similarities, differences and other 
patterns within and across transcripts.15 Participants did 
not provide feedback on the overall findings.
Patient and public involvement
Patients and the public were not involved in the design or 
conduct of this study.
RESULTS
Sixteen GPs and 14 patients participated in the study. 
Table 2 shows the characteristics of participants.
Twelve GP participants were female and 13 had more 
than 20 years of practice. None of the GP participants 
agreed with the statement ‘Everyone who gets low back 
pain should have an imaging test (x- Ray, CT, MRI)’. Thir-
teen GP participants reported requesting imaging in 
fewer than a quarter of their consultations for musculo-
skeletal imaging and eight had an interest in musculo-
skeletal conditions.
Eleven patient participants were born outside of 
Australia, 12 were between 20 and 60 years of age, and 6 
had a university education or higher. All patient partici-
pants had had an imaging test in the past, and 11 believed 
everyone with low back pain should have imaging.
We summarise the key findings with selected quotes 
in the following sections. During the analysis the author 
team agreed that the clearest format to present the results 
was to present views of the two groups of participants 
separately. Additional supporting quotes (numbered in 




GPs had mixed reactions to the tools (box 2). Some GPs 
felt the communication tools could have a role in helping 
to manage difficult consultations:
I guess if you had a really stroppy patient you didn’t 
know and didn’t think you’d get any follow up with, 
perhaps there could be a role. (GP focus group)
However, most GPs reacted negatively to the Dialogue 
Sheet and Wait- and- see Note, and none of them reported 
they would use these in practice. They found the concept 
of written prompts and co- signing an agreement with their 
patient to be an insult to their clinical skill and autonomy:
Box 2 Summary of general practitioner (GP) and 
patient views on communication tools to support delayed 
prescribing of imaging for low back pain
GP views.
Reaction to Overdiagnosis Leaflet.
 ► Useful, visually appealing information.
 ► May increase anxiety and discourage necessary care.
 ► Digitise tools, communicate using other media in waiting room.
Reaction to Dialogue Sheet.
 ► Preference for verbal communication.
 ► Could add to time pressure.
 ► Reluctance to sign.
Reaction to Wait- and- see Note.
 ► Validating messages.
 ► Preference for verbal communication.
Workforce issues (all tools).
 ► Experienced GPs do not need these tools.
Concerns about patient pushback (all tools).
 ► Tools could undermine the patient–clinician relationship.
 ► Patients’ (mis)interpretation of ‘harms’.
Patient views.
Reaction to Overdiagnosis Leaflet.
 ► Authoritative, informative, reassuring, encourages discussion.
 ► Desire for less emphatic language.
 ► May increase anxiety, cause anger and discourage necessary care.
Reaction to Dialogue Sheet.
 ► Appreciated as a take- home tool/memory aid.
 ► Co- signed agreement could have mixed response.
Reaction to Wait- and- see Note.
 ► Uses dismissive terminology (eg, ‘wait’).
 ► Easily ignored.
Understanding and interpretation of content (all tools).
 ► Understood concept of overdiagnosis but were sceptical of its 
magnitude.
 ► Desire for clear definition of ‘harm’.
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No, no, I’d never use [the dialogue sheet] in a pink fit. 
(GP focus group)
GPs felt paper- based tools in general were impractical 
and easily forgotten, and preferred verbal reassurance:
Would I use [the dialogue sheet and note]? Probably not. 
I, probably again, I would document [instruction to de-
lay] in the notes. I do document this sort of thing in 
the notes. (Female GP, 20+ years of experience)
GP reactions to the Overdiagnosis Leaflet: important content that 
would be useful in digital format, but may induce patient anxiety
GP participants responded most positively to the design 
and content of the Overdiagnosis Leaflet. They valued the 
condition- specific information such as clinical features 
for lumbar imaging and self- management advice (Q1). 
Some felt the language of the leaflet was too emphatic 
and could discourage necessary imaging:
I mean [the overdiagnosis leaflet] would scare them off 
having a scan and maybe it might scare some of the 
1% who do need to have it. (GP focus group)
GP participants expressed a strong preference for easily 
accessible, web- based or electronic medical record- based 
fact sheets for use with their patients (Q2).
GP reactions to the Dialogue Sheet: redundant for experienced 
GPs, would add to time pressure
Most GP participants felt the Dialogue Sheet would be 
superfluous, and preferred to communicate the same 
messages verbally:
So, as I said, that’s the sort of thing I would be telling 
the patient as we went, and maybe summarising at the 
end, but I would do that in a verbal fashion. I wouldn’t 
be filling in a form like this. (GP focus group)
Some were concerned the tools would just add to time 
pressure within the consultation:
So, if the patient is going to have to sit down and read 
this, and try to understand it, and then sign it, it’s just 
going to lengthen things out. It’s just not going to be 
feasible. (GP focus group)
Most GP participants did not want to sign the Dialogue 
Sheet and felt that patients would be opposed to signing 
it as well:
It doesn’t need a contract, we’re not giving morphine 
out. (GP focus group)
GP reactions to the Wait-and-see Note: could help validate 
concerns, but impractical
One doctor noted that the language of the Wait- and- see 
Note could help validate a patient’s experience:
I guess what the writer was trying to get across was: ‘I 
acknowledge that you have real symptoms.’ I think 
that’s better, the patient wants me to know that they 
really have pain. (GP focus group)
A key barrier to use of the note was practicality. Partic-
ipants felt verbal communication of similar messages 
would be more efficient (Q3).
Workforce issues and concerns about patient pushback (all tools)
Some GP participants felt the communication tools 
were more useful for less experienced doctors or in the 
community more broadly (Q4):
This [overdiagnosis leaflet] is a document that absolute-
ly needs to go [beyond] primary care level, at a com-
munity level. (GP focus group)
GPs felt the Dialogue Sheet and Wait- and- see Note 
would be patronising to patients or could compromise 
the clinician–patient relationship:
These pieces of paper are the opposite [to patient 
centered care], these are all giving me, the doctor, the 
Table 2 Participant characteristics (N=30)
Characteristics
Participants (n)
Patients (n=14) GPs (n=16)
Age
  20–39 5 2
  40–59 7 5
  60–79 2 9
Sex
  Female 9 12
  Male 5 4
Born outside of Australia
  Yes 11 –
  No 3 –
University education
  Yes 6 –
  No 8 –
Had an imaging test for back 
pain in the past
14 –
Believe everyone with low back 
pain should have a scan
11 0
Years practising as a GP
  1–9 – 2
  10–19 – 1
  20+ – 13
Self- reported imaging request rate
  <10% – 6
  ~25% – 7
  ~50% – 2
  >75% – 1
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power. And the patient is the person who’s below me 
doing what I have told them. (GP focus group)
[If I were to use it with my patients] They’d probably think 
I’ve gone mad. (Female GP, 20+ years of experience)
Patient views
Overall patient reactions
Patients generally had positive reactions to all three 
tools (box 2). In contrast to GP responses, patients 
valued paper- based, written information and the 
perceived accountability that a co- signed agreement 
section on the Dialogue Sheet and Wait- and- see Note 
would provide:
I hate it when they don’t keep their word to see you 
again. So this one, when they sign on it, they have to 
see you. (Patient focus group)
For some, the perceived benefit of locating the source 
of low back pain, and ruling out serious pathology, 
outweighed any advice to delay an imaging test (Q5). 
Others regarded the tools with suspicion:
I’m just now thinking maybe the doctors, the gov-
ernment, whatever, want all the people with the back 
pain not to do the scans any more. Why? (Patient fo-
cus group)
Patient reactions to the Overdiagnosis Leaflet: informative but 
alarming, prompts desire to discuss harms of imaging with GP
Most patient participants found the Overdiagnosis Leaflet 
clear, informative and credible:
I’m assuming the quote comes from Professor Ian 
Harris at the bottom of the page. So yeah I think it’s 
a fairly accurate statement, easy to understand, good 
advice. I guess it’s clarified that he’s an orthopaedic 
surgeon so that adds some weight to the comment. 
(Male patient, 40–59 years old)
Some patients felt the Overdiagnosis Leaflet would 
encourage them to ask their doctor questions about their 
care (Q6). Other patient participants were reluctant to 
challenge the perceived authority of their doctor:
I just don’t know if [my GP] would be comfortable 
hearing that from a patient. (Male patient, 20–39 
years old)
There was concern among patient participants that 
the Overdiagnosis Leaflet would discourage imaging 
for those who did need it (Q7). One patient participant 
reacted angrily to the concept that some scans might be 
unnecessary:
Telling me that a scan is not going to find something 
is a waste of my time. Not a waste of my time, but I’m 
angry as soon as I see it. I’m pissed off at that. (Patient 
focus group)
Patient reactions to the Dialogue Sheet: could improve recall of the 
consultation and provide evidence of GP commitment
In contrast to the Overdiagnosis Leaflet, which provoked 
some concerns, the Dialogue Sheet had potential to be 
reassuring. Patients had mixed reactions to the concept 
of co- signing an agreement to not have an imaging test; 
some felt it would be an odd process (Q8), where others 
appreciated the clinician’s commitment:.
… if he says he reviews us in two weeks, and he’s 
signed it as well, if you come and he cancels it, it’s 
on him. So it’s peace of mind. (Patient focus group 
participant)
Patient reactions to the Wait-and-see Note: uses dismissive 
terminology and would be easy to ignore
Some patient participants found the concept of the Wait- 
and- see Note dismissive. One patient participant, who was 
an allied health professional, felt patients might ignore 
the note:
I think, personally, people, if they’ve got the referral 
there, I think they would just ignore that [message to] 
wait- and- see. (Female patient, 40–59 years old)
Patient understanding and interpretation of content (all tools): take 
care with language to describe overdiagnosis and related harms
There was some suspicion among patient participants 
about the veracity of the data on the magnitude of overdi-
agnosis in the leaflet (Q9). One patient participant 
understood the link between overdiagnosis and unneces-
sary surgery, but felt the odds of this happening were not 
concerning:
…so only one will have surgery and they don’t need 
it. So 1 out 100? [Facilitator: Yeah, not that bad do you 
reckon?]. Well yeah not that bad. (Patient focus group)
The term ‘false alarm’ was a poorly understood concept. 
Some patient participants felt the term indicated that 
their problem was imaginary (Q10).
DISCUSSION
Summary
The GPs and the patients we interviewed had divergent 
views on the value of the three different communication 
tools to support delayed prescribing of imaging for low 
back pain. While almost all GPs rejected a tool with an 
example dialogue and discussion points, patients desired 
this process. Some patients appreciated the concept of 
co- signing an agreement to delay imaging, while others 
did not. The GPs we interviewed universally rejected this 
co- signing approach. There was variation in what patients 
and GPs considered to be a ‘harm’ from having imaging.
Strengths and limitations
We conducted this study at a time when advanced imaging 
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patients might use communication tools will help inform 
strategies to reduce this problem. We used a combina-
tion of focus groups and interviews and sampled people 
involved in the decision to have diagnostic imaging in 
emergency and primary care. This allowed us to capture 
natural conversations in the groups and explore emer-
gent themes in depth in the interviews.
We were restricted to recruiting mainly from a GP 
professional development network, with a small number 
of additional participants recruited through an additional 
study. This group may have had more positive views than 
expected in the wider population of GPs, although our 
data suggest they were highly sceptical of the materials 
and divergent from patients. Unfortunately, none of the 
four GPs who offered to take the tools away could reflect 
on the use of the tools in practice, either because they did 
not see an appropriate patient in the 3- week period or 
because they forgot. This means that the views expressed 
here are restricted to hypothetical, rather than expe-
riential, use of these tools. Although all of the patients 
we included had seen a GP for their low back pain, they 
had also attended the emergency department of a public 
hospital for their low back pain. This diverse group of 
patients may be different from those who typically attend 
a GP as their first or only contact with the health system. 
The patient participants in this study might also repre-
sent a group who take low back pain very seriously and be 
more critical of tools to delay or deter imaging.
Comparison with existing literature
Our findings are consistent with research showing that 
attempts to reduce or delay tests can arouse suspicion 
about financial arrangements, government oversight and 
motives to cut costs.16 This phenomenon also occurs in 
women considering breast cancer screening.17 Our study 
confirms that mistrust among patients could extend to 
communicating about delayed imaging, overdiagnosis 
and the option of watchful waiting.
We are aware of one other study that evaluated reac-
tions to a communication tool to support GPs to reduce 
unnecessary imaging of low back pain. Jenkins et al18 exam-
ined GP and health consumer (community members 
with a history of low back pain) reactions to a booklet 
about lumbar imaging. Similar to our findings, some 
GPs preferred digital format, whereas health consumers 
appreciated a glossy hard copy to take home to discuss 
with their family. Health consumers valued detailed, 
written, individualised information and reassurance. Our 
findings suggest that patients may also desire tools that 
provide them with a sense that the GP has taken them 
seriously. The co- signed section in the Dialogue Sheet 
and Wait- and- see Note appeared to achieve this, yet GPs 
had reservations about using it.
Trials of patient- mediated interventions to reduce 
imaging rates have had limited success and suggest chal-
lenges to uptake.19 For example Schectman et al20 found 
no effect of patient education tools on imaging rates in 
their trial including 120 GPs, but only one- third of GPs 
reported using the tools in the trial. Given the diver-
gent and sometimes strong views expressed in this study, 
ongoing evaluation of communication tools to meet the 
needs of end users appears essential.
The patients we interviewed reacted with surprise to the 
nature and magnitude of imaging overdiagnosis. Many of the 
patient participants struggled to think of harms of diagnostic 
imaging, other than exposure to radiation. This finding 
supports evidence on patient perceptions of overused 
screening tests, for example, the perception that the benefits 
of early detection tend to outweigh the harms of unnecessary 
tests.21 Our findings on how GPs describe harms from overdi-
agnosis suggest that they may also hold this view.
Implications for future research and practice
This study provides insights into the complexity of commu-
nicating about unnecessary imaging . Based on these find-
ings there may be several ways to enhance acceptability and 
uptake of delayed prescribing approaches. First, the language 
relating to the necessity of diagnostic imaging tests should be 
cautious rather than emphatic. Patients may interpret harms 
differently; tools that describe risk of ‘harms’ would benefit 
from also providing clear examples of overdiagnosis. Second, 
tools should be in digital format for GPs, but readily printed 
for patients who prefer paper- based information. We may not 
have reached saturation on the key ways a GP might integrate 
communication tools into their workflow. Future research on 
how best to integrate delayed prescribing tools into workflow 
(eg, via access to leaflets, printed tear- off sheets, web- based or 
app- based tool, electronic medical record- based tools) would 
be informative for initiatives to reduce overuse. Finally, the 
Dialogue Sheet with or without a co- sign agreement section 
requires further testing before implementing this kind of 
tool in clinical practice. Together our findings suggest that 
an information leaflet that explains the problem of overdi-
agnosis could support a delayed prescribing approach to 
imaging for low back pain. The Dialogue Sheet and Wait- 
and- see Note to help discuss delayed imaging may be accept-
able to patients but not to GPs.
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Appendix 1 - COREQ checklist  
 
The Consolidated Criteria for Reporting Qualitative Studies (COREQ): 32-item checklist  
(Table developed from Tong et al., 2007) 
 
No.  Item  Guide questions/description Page Number 
Domain 1: Research team and reflexivity  







Which author/s conducted the interview or focus 
group?  
7 
2. Credentials What were the researcher’s credentials? E.g. 
PhD, MD  
1 
3. Occupation What was their occupation at the time of the 
study?  
6 
4. Gender Was the researcher male or female?  7 
5. Experience and 
training 
What experience or training did the researcher(s) 
have?  
7 
Relationship with participants  
6. Relationship 
established 




knowledge of the 
interviewer  
What did the participants know about the 
researcher? e.g. personal goals, reasons for doing 




What characteristics were reported about the 
inter viewer/facilitator? e.g. Bias, assumptions, 
reasons and interests in the research topic  
7  
Domain 2: Study design 




What methodological orientation was stated to 
underpin the study? e.g. grounded theory, 
discourse analysis, ethnography, 
phenomenology, content analysis  
9 
Participant selection  
10. Sampling How were participants selected? e.g. purposive, 
convenience, consecutive, snowball  
5 
11. Method of 
approach 
How were participants approached? e.g. face-to-
face, telephone, mail, email  
6 
12. Sample size How many participants were in the study?  6,10 
13. Non-
participation 
How many people refused to participate or 
dropped out? Reasons?  
6 
Setting   
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14. Setting of data 
collection 




15. Presence of 
non-participants 
Was anyone else present besides the participants 
and researchers?  
8 
16. Description of 
sample 
What are the important characteristics of the 
sample? e.g. demographic data, date  
10 
Data collection    
17. Interview 
guide 
Were questions, prompts, guides provided by the 










Did the research use audio or visual recording to 
collect the data?  
7 
20. Field notes Were field notes made during and/or after the 
interview or focus group?  
7 





Was data saturation discussed?  5,8 
23. Transcripts 
returned 
Were transcripts returned to participants for 
comment and/or correction?  
7 
Domain 3: Analysis and findings  
Data analysis 
24. Number of 
data coders  
How many data coders coded the data?   9 
25. Description of 
the coding tree 
Did authors provide a description of the coding 
tree?   
9 
26. Derivation of 
themes 
Were themes identified in advance or derived 
from the data? 
9 
27. Software What software, if applicable, was used to 










Were participant quotations presented to 
illustrate the themes/ findings? Was each 
quotation identified? E.g. participant number 
10-18 
30. Data and 
findings 
consistent 
Was there consistency between the data 
presented and the findings?  
10-18 
31. Clarity of 
major themes  
Were major themes clearly presented in the 
findings? 
10-18 
32. Clarity of 
minor themes 
Is there a description of diverse cases or 
discussion of minor themes?  
10-18 
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Appendix 2 - Tools 
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Appendix 3 – Additional supporting quotes 
 
 
Q1 “It’s got great statements, it’s got statistics, it’s a beautiful document. Not sure about 
the colours, but the document is great.” (GP focus group) 
 
Q2 “Young people don’t like paper any more. So if you can send it to them so they can have 
it on their phone [that would be better than paper].” (GP focus group) 
 
Q3 “You just tell them verbally most people will get better but, if you’re not, then you can 
go and have this.” (GP focus group) 
 
Q4 “I think this could be good for a junior doctor, registrar who are not empowered as 
opposed to more experienced GPs with their loyal patient base.” (GP focus group) 
 
Q5 “I want to know what’s happening inside me and the best way to know is to have an MRI 
scan. That’s what we’ve been taught for many years that’s what the doctors have said to us. 
Maybe the new generation can have a different view on it, but from my perspective, I think I 
would have my ultrasound. I want to know what’s happening inside.” (Male patient, 20-39 
years old) 
 
Q6 “I like it. ‘What if I don’t have a scan?’ I find that a really interesting question because 
yeah, I suppose it just allows more communication by asking that question…. it opens up 
that communication path again.” (Female patient, 40-59 years old) 
 
Q7 “it potentially causes alarm for people who are going to require a scan.” (Male patient, 
40-59  years old) 
 
Q8 “I don’t think signing it really adds any value to it, it just seems a bit strange. It’s like 
you’re entering into a contract. It just seems a bit unusual to have to sign the document.” 
(Male patient, 40-59  years old) 
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Q9“Is it real data we’re looking at?” (Patient focus group) 
 
Q10“…reading the narrative of that just tells me that perhaps I’m playing it up a bit in my 
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